Application
TCEB3 Antibody (Center) western blot analysis in Hela cell line lysates (35ug/lane).This demonstrates the TCEB3 antibody detected the TCEB3 protein (arrow).| Product Name | TCEB3 Antibody (Center) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | TCEB3; Transcription elongation factor B polypeptide 3; Elongin 110 kDa subunit; Elongin-A; RNA polymerase II transcription factor SIII subunit A1; SIII p110 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | TCEB3 Transcription elongation factor B polypeptide 3 Elongin 110 kDa subunit Elongin-A RNA polymerase II transcription factor SIII subunit A1 SIII p110 |
|---|---|
| Molecular Weight(MW) | 89909 Da |
| Function | SIII, also known as elongin, is a general transcription elongation factor that increases the RNA polymerase II transcription elongation past template-encoded arresting sites Subunit A is transcriptionally active and its transcription activity is strongly enhanced by binding to the dimeric complex of the SIII regulatory subunits B and C (elongin BC complex) |
| Tissue Specificity | This TCEB3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 252-282 amino acids from the Central region of human TCEB3. |
| Cellular Localization | Nucleus (Probable). |
| Entrez Gene | 6924 |
|---|---|
| Nucleotide Accession | NP_003189.2 |
Application
TCEB3 Antibody (Center) western blot analysis in Hela cell line lysates (35ug/lane).This demonstrates the TCEB3 antibody detected the TCEB3 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
